Healthcare of Ontario Pension Plan Trust Fund Invests $9.40 Million in Olink Holding AB (publ) (NASDAQ:OLK)

Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of Olink Holding AB (publ) (NASDAQ:OLK) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 400,000 shares of the company’s stock, valued at approximately $9,404,000. Healthcare of Ontario Pension Plan Trust Fund owned about 0.32% of Olink Holding AB (publ) at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. FIL Ltd acquired a new position in shares of Olink Holding AB (publ) in the fourth quarter valued at about $204,394,000. Alpine Associates Management Inc. acquired a new position in shares of Olink Holding AB (publ) during the 4th quarter worth approximately $47,302,000. Water Island Capital LLC bought a new position in shares of Olink Holding AB (publ) during the fourth quarter worth approximately $41,360,000. Tokio Marine Asset Management Co. Ltd. acquired a new stake in shares of Olink Holding AB (publ) in the fourth quarter valued at approximately $16,735,000. Finally, Gardner Lewis Asset Management L P acquired a new stake in Olink Holding AB (publ) during the fourth quarter worth approximately $10,403,000. 30.19% of the stock is owned by institutional investors and hedge funds.

Olink Holding AB (publ) Stock Performance

Olink Holding AB (publ) stock remained flat at $26.08 during mid-day trading on Thursday. The company’s stock had a trading volume of 2,206 shares, compared to its average volume of 633,228. The firm’s 50 day simple moving average is $25.11 and its two-hundred day simple moving average is $24.20. The company has a market cap of $3.24 billion, a price-to-earnings ratio of -96.59 and a beta of 0.52. Olink Holding AB has a 12-month low of $14.10 and a 12-month high of $26.09.

Olink Holding AB (publ) (NASDAQ:OLK) last issued its quarterly earnings results on Monday, May 13th. The company reported ($0.13) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.01). Olink Holding AB (publ) had a negative return on equity of 7.07% and a negative net margin of 19.72%. The company had revenue of $28.75 million during the quarter, compared to the consensus estimate of $31.29 million. As a group, research analysts expect that Olink Holding AB will post -0.19 EPS for the current year.

Olink Holding AB (publ) Profile

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on.